Skip to main content

University of Kansas Medical Center Research Institute

KUMCRI > News from the RI > Research Institute Newsletter – April 2015

Research Institute Newsletter – April 2015

Positive momentum: a message from President Richard J. Barohn, M.D.

Dr. Richard Barohn

So far, 2015 has been a time of positive change and forward momentum at the University of Kansas Medical Center Research Institute. Following a national search, we have hired Jamie Caldwell, MBA, as our new executive director. He comes to us from the University of Loyola in Chicago, and three months into his tenure, he is working diligently to meet new people and to help carry the message to our broader community that the Research Institute will provide the best customer service possible.

All of us at the KU Medical Center Research Institute hope that you will take the time to re-acquaint yourselves with the services we can provide. If you are conducting a clinical trial, receiving external research funding or are involved at all in the research enterprise of our institution, the Research Institute exists to support your needs.

This newsletter is designed to let you know some of what we can do for you. We have new staff members to announce, faculty members who have received external funding awards, details about services that the Research Institute can provide and more. 

Thanks for taking the time to read some of the messages from various Research Institute leaders. 

Richard J. Barohn, M.D.
Vice Chancellor for Research
President, KUMC Research Institute

Getting started: a message from Executive Director Jamie Caldwell, MBA

Jamie CaldwellGreetings!
It has been three months since I stepped onto the University of Kansas Medical Center campus.  I can honestly say it has been an exciting three months. So far, I have been learning the ropes of the KUMC campus and the Research Institute. I have enjoyed meeting with many different stakeholders of the research community, and I have attended several departmental faculty meetings to share my vision and commitment to research and research administration. I anticipate attending more faculty meetings over the coming weeks and months.

We've had a number of staff changes recently, particularly in our Clinical Research Administration division. We have repositioned Caroline Murray as Assistant Director of Regulatory Management, where she will oversee the clinical regulatory specialists. Meanwhile, we have promoted Anne Hoffman to Assistant Director, Budget and Contracts, where she will oversee budgets and contracts analysts. With these changes, the vacant director of Clinical Research Administration position will be placed on hold until further notice.

Dr. Richard Barohn, vice chancellor for research and president of the Research Institute, and I welcome you to explore the first of what we hope will be many online news, notes and updates from the KUMC Research Institute.

Mission Statement
The mission of the Research Institute is to support the research enterprise and to promote and support scientific discovery by providing the best quality service possible to our faculty, staff and students. 

Goals and Objectives:

  • Serve KUMC by promoting and operating at the highest level in providing a customer service environment, yet recognizing our fiduciary responsibility and upholding ethical standards.
  • Foster relationships among individual, multiple and consortium partnerships on behalf of KUMC researchers at the local, state, national and international biomedical research communities.
  • Foster relationships among our researchers and the technology transfer community, capitalizing on our discovery through research opportunities with the private sector.
  • Facilitate cooperative and productive research partnerships, both domestically and internationally among KUMC, KU-Lawrence, research centers and other bioscience organizations throughout the Kansas and the Greater Kansas City metropolitan area. 

Jamie Caldwell, MBA
Associate Vice Chancellor for Research Administration
Executive Director, KUMC Research Institute

Budget assistance is available for clinical trial or clinical research projects

Do you have a planned research project and a potential funding source? The Research Institute Budget and Contract office can help.

There may be more costs involved in your project than you think. The RI can help ensure all your hidden costs are identified and incorporated into your budget before you approach your potential funding source. Our staff can review your protocol and help identify what costs your project should be prepared to consider, and help you make the best use of finite resources.

For more information, please contact Anne Hoffman, Assistant Director of Budgets & Contracts, at 913-588-1242 or via email at

For budget questions related to sponsored projects funded by federal agencies or private foundations, please contact Deborah Maloney at 913-588-6570 or email for assistance.

Growth and change among staff who can assist with clinical trials

There have been many recent changes in personnel in the Clinical Research Administration Division of the KUMC Research Institute, which assists researchers in conducting clinical trials. You may have noticed new names appearing in your research communications, while others with whom you are already familiar have assumed new roles. We would like to take this opportunity to reintroduce the current staff in the Division of Clinical Research Administration:

Regulatory Management

  • Caroline Murray, CCRC, Assistant Director of Regulatory Management ( / 8-5718) – Disease Groups: Preventive Medicine, OB/GYN, Hematology/Oncology. Caroline joined the Research Institute in November 2014.
  • Jeanna Julo, BA, BS, CCRP, Senior Clinical Trials Regulatory Specialist ( / 5-6861) – Disease Groups: Neurology (Huntington’s, Parkinson’s, epilepsy), Surgery (General, Plastic, Urologic), Wichita studies. Jeanna has been with the RI since January 2011.
  • Lindsey Atchity, BS, Clinical Trials Regulatory Specialist ( / 8-5238) – Disease Groups: Allergy/Immunology/Rheumatology, Neurology (neuromuscular), Metabolic & Endocrine, Pathology/Laboratory Medicine, Pediatrics. Lindsey has been with the RI since December 2012.
  • Derek Kern, BA, Clinical Trials Regulatory Specialist (, 8-8831) – Disease Groups: Cardiovascular, Integrative Medicine, Dietetics & Nutrition, Geriatric Medicine, Emergency Medicine, Orthopedic Surgery, Radiology. Derek has been with the RI since December 2013.
  • Johnathan Evans, Clinical Trials Regulatory Specialist (, 8-2048) – Disease Groups: Anesthesiology, GI, Pulmonary, Neurology (Headache & Stroke). Johnathan started with the RI in August 2014.
  • Jill Drucker, MS, Clinical Trials Regulatory Specialist (, 8-2051) – Disease Groups: Infectious Disease, Neurology (Alzheimer’s disease), Neurosurgery, Pharmacology, Clinical Pharmacology, Physical Therapy, Occupational Therapy Education. Jill started with the RI in September 2014.
  • Russell Schroeder, BS, COA, CCRP, Clinical Trials Regulatory Specialist (, 8-8830) – Disease Groups: Nephrology, Neurology (multiple sclerosis), Ophthalmology, Otolaryngology, Psychiatry. Russell joined the RI in September 2014.
  • Audrey King, BS, Clinical Trial Regulatory Specialist (, 8-5751). Audrey joined the RI in March 2015 and will be assigned to disease groups after her training is completed.
  • Kaitlyn Gerwick, BS, Clinical Trial Regulatory Specialist (, 8-6092). Kaitlyn joined the RI in March 2015 and will be assigned to disease groups after her training is completed.
  • Tiffany Robinson, BA, Clinical Trial Regulatory Specialist (, 85705). Tiffany also joined the RI in March 2015 and will be assigned to disease groups after her training is completed.

Budgets & Contracts

  • Anne Hoffman, BS, BA, CCRP, Assistant Director of Budgets & Contracts (, 8-1242) – Disease Groups: Emergency Medicine, Neurology (epilepsy, Parkinson’s, neuromuscular, headache & stroke), Allergy/Immunology/Rheumatology, Metabolic & Endocrine, Psychiatry, Neurosurgery, Pharmacology, Clinical Pharmacology, Wichita studies. Anne was recently promoted to the position of Assistant Director, having previously been Senior Budget & Contract Specialist. Anne has been with the RI since January 2011.
  • Hailey Osland, JD, Budget & Contract Analyst (, 8-0127) – Disease Groups: Anesthesiology, Otolaryngology, Pathology & Laboratory Medicine, Cardiovascular, Surgery (urologic, plastic, orthopedic, general). Hailey has been with the RI since October 2014.
  • Kristy Williamson, MPH, Budget & Contract Analyst (, 8-1251) – Disease Groups: Integrative Medicine, Dietetics & Nutrition, Geriatric Medicine, Radiology, Neurology (Huntington’s, multiple sclerosis, Alzheimer’s disease), Pediatrics, OB/GYN, Preventive Medicine, Nephrology, Ophthalmology, GI, Pulmonary, Infectious Disease, Occupational Therapy Education, Physical Therapy. Kristy joined the RI in September 2014.
  • Chad O’Neill, JD, Budget & Contract Analyst (, 8-2049). Chad joined the RI in March 2015and will be assigned to disease groups after his training is completed.

Research Audit & Quality Assurance

  • Kevin Smilor, BS, Research Audit & QA Manager (, 8-3230) – Disease Groups: Breast Cancer Prevention. Kevin has been with the RI since July 2011.

Researchers receiving externally funded projects

The following KU Medical Center projects have received external funding for projects scheduled to start Jan. 1, 2015 or later, listed alphabetically by principal investigator. This list includes funding for new projects and competing renewals.

  • $5,000 to Lauren S. Aaronson from the Oncology Nursing Society for the proposal “Gene Expression and Fatigue in Puerto Rican Men.”
  • $10,017,143 to Christie A. Befort from the Patient-Centered Outcomes Research Institute for the proposal “Midwestern Collaborative for Treating Obesity in Rural Primary Care.”
  • $71,804 to Sandra L. Bergquist Beringer from the Competency and Credentialing Institute for the proposal “The Relationship between Nursing Specialty Certification and Surgical Site Infection Rates in Acute Care Hospitals.”
  • $15,000 to Jack A. Brown from Wichita Medical Research and Education for the proposal “Environmental and Health Needs After Ground Water Contamination in Wichita.”
  • $33,660 to Guoqing Chen from the Midwest Biomedical Research Foundation for the proposal “Support VA Physicians projects with Data Analyst-service of Scott Koertner.”
  • $7,800 to Emily C. Cramer from the American Nurses Association for the proposal “Safe Patient Handling and Mobility Environment Scan.”
  • $2,808,178 to Joseph E. Donnelly Jr. from the NIH for the proposal “Weight Management for Adolescents with IDD.”
  • $49,838 to Winifred Dunn from the American Occupational Therapy Foundation for the proposal “Feasibility of a Telehealth Coaching Intervention for Rural Families of Children with Autism.”
  • $124,625 to Andrew K. Godwin from the University of Texas Health Science Center [NIH] for the proposal “EDRN - San Antonio Center for Biomarkers of Risk for Prostate Cancer [SABOR].”
  • $415,250 to Janna L. Harris from the NIH for the proposal “Taurine Treatment for Traumatic Brain Injury in Aging.”
  • $5,000 to Chenjuan Ma from Sigma Theta Tau for the proposal “Unit Climate of Teamwork and Nursing Leadership and the Effects on Patient Outcomes.”
  • $70,000 to Heather D. Schrotberger from the Greater KC Community Foundation for the proposal “Project EAGLE- Early Steps to School Success.”
  • $10,000 to Neil A. Segal from the Foundation for Physical Medicine and Rehab for the proposal “Determining Efficacy of the Combined Application of Electrical Stimulation and Volitional Contractions for Knee Pain Inhibition and Physical Function Improvement in Men and Women with Knee Osteoarthritis.”
  • $632,273 to Joseph S. Tash from the National Aeronautics and Space Administration for the proposal “Female reproductive health: Space flight induced ovarian & estrogen signaling dysfunction, adaptation, and recovery.”
  • $1,764,431 to Pamela V. Tran from the NIH for the proposal “Hedgehog signaling as a potential therapeutic target for cystic kidney disease.”
  • $1,927,018 to Shahid Umar from the NIH for the proposal “Epigenetics and Infection-induced EMT of Colonic Crypts - Target for Chemoprevention.”
  • $3,000 to Eric D. Young from the Melanoma Research Foundation for the proposal “Using the Pulmonary Metastasis Assay (PuMA).”

New changes for researchers with sponsored projects

Researchers with sponsored projects may note some changes in allowable costs, close out dates and subaward contracts on proposals.The following are changes based on the 2 CFR 200 Uniform Guidance (UG) which took effect on December 26th 2014. The UG supersedes the Office of Management and Budget Circulars A21, A-110 and A-133. KUMC Research Institute policies are currently being updated to reflect the changes in the UG.


  • Close out a project must be completed within 90 days of the project period end date.


  • If a sub-recipient has a federally negotiated F&A rate, that rate must be used in budget preparations/proposal submissions. If the sub-recipient does not have a federally negotiated rate, then a 10% F&A de minimis rate must be used, unless no F&A rate is required by the sub-recipient.


  • Computing devices: The 2 CFR 200 defines Computing Devices as machines that cost less than $5,000 and are used to acquire, store, analyze, process, and publish data and other information electronically, including accessories (or “peripherals”) for printing, transmitting and receiving, or storing electronic information. Computing devices may be direct charged to a federal award if it can be justified as essential and allocable, but not solely dedicated to the project. All computing devices must adhere to the KUMC Information Systems purchasing procedures and security policies.
  • Publication costs: Publication costs on federal awards are allowable during the period of performance and the 90-day closeout period.
  • Salaries for administrative personnel and other departmental expenses: Salaries for administrative or clerical services are not normally allowed to be charged to federal grants or contracts. However, there are some exceptions to this federal guideline if the specific situation meets all of the following conditions:
    • Administrative or clerical services are integral to a project or activity.
    • People involved can be specifically identified with the project or activity.
    • Such costs are explicitly included in the budget or have the prior written approval of the federal awarding agency.
    • The costs are not also recovered as indirect costs.
  • Visa costs as part of recruitment: Short-term visa costs as part of the recruitment process may be direct charged on federal awards. These costs must be critical and necessary for the conduct of the project, and be allowable under the applicable cost principles. Basic visa application and required fees, such as anti-fraud fees, are allowable direct costs provided they meet the above. Longer-term, premium or expedited fees, dependent fees, or renewal fees are NOT allowable as direct charges to a federal award.

In Memoriam: Ruth Brennaman

Ruth Brennaman, sponsored programs coordinator for the KUMC Research Institute, died March 27. Services are set for Saturday. She had served several roles for the KUMC RI since becoming an employee in 2007, and will be greatly missed by her friends and colleagues.

Ruth Brennaman

Last modified: Aug 30, 2018